Atlas Trials

Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC

Clinical trial NCT02018757 · UNKNOWN

Trial details

NCT number
NCT02018757
Sponsor
First Hospital of China Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2014-01-01
Primary completion
2015-12-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.